Activation of intestinal mast cells contributes to gut damage after cardiac arrest in mice.

IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE
SHOCK Pub Date : 2025-06-06 DOI:10.1097/SHK.0000000000002640
Lihong Dang, Ata Ur Rehman, Jin Zhang, Ran Zhang, Xinyuan Yu, Huaxin Sheng, Jörn Karhausen, Wei Yang
{"title":"Activation of intestinal mast cells contributes to gut damage after cardiac arrest in mice.","authors":"Lihong Dang, Ata Ur Rehman, Jin Zhang, Ran Zhang, Xinyuan Yu, Huaxin Sheng, Jörn Karhausen, Wei Yang","doi":"10.1097/SHK.0000000000002640","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Sudden cardiac arrest (CA) is associated with high mortality and morbidity rates, largely due to detrimental effects of global ischemia on every organ. Notably, clinical evidence indicates that gastrointestinal tract damage is frequently observed in successfully resuscitated CA patients and suggests that this damage has a negative impact on prognosis. However, experimental CA studies have rarely examined this clinically relevant pathologic change and as such, little is known about the underlying mechanisms. Here, we provide the first evidence that mast cells (MCs) play a critical role in gut damage after CA. Our data first showed notable activation of intestinal MCs and evidence of disrupted gut integrity following CA in a mouse model. Then, using both pharmacologic and genetic tools, we found that treatment with the MC activator C48/80 significantly increased gut permeability, while gut function was better preserved in MC-deficient mice compared to wild-type mice. Together, our results identified MC activation as a critical pathologic process driving post-CA gut damage.</p>","PeriodicalId":21667,"journal":{"name":"SHOCK","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324823/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"SHOCK","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/SHK.0000000000002640","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: Sudden cardiac arrest (CA) is associated with high mortality and morbidity rates, largely due to detrimental effects of global ischemia on every organ. Notably, clinical evidence indicates that gastrointestinal tract damage is frequently observed in successfully resuscitated CA patients and suggests that this damage has a negative impact on prognosis. However, experimental CA studies have rarely examined this clinically relevant pathologic change and as such, little is known about the underlying mechanisms. Here, we provide the first evidence that mast cells (MCs) play a critical role in gut damage after CA. Our data first showed notable activation of intestinal MCs and evidence of disrupted gut integrity following CA in a mouse model. Then, using both pharmacologic and genetic tools, we found that treatment with the MC activator C48/80 significantly increased gut permeability, while gut function was better preserved in MC-deficient mice compared to wild-type mice. Together, our results identified MC activation as a critical pathologic process driving post-CA gut damage.

肠道肥大细胞的激活有助于心脏骤停后小鼠肠道损伤。
摘要:心脏骤停(CA)具有很高的死亡率和发病率,主要是由于全身缺血对各个器官的有害影响。值得注意的是,临床证据表明,在成功复苏的CA患者中经常观察到胃肠道损伤,并表明这种损伤对预后有负面影响。然而,实验性CA研究很少检查这种临床相关的病理变化,因此,对其潜在机制知之甚少。在这里,我们首次提供了肥大细胞(MCs)在CA后肠道损伤中发挥关键作用的证据。我们的数据首先在小鼠模型中显示了肠道MCs的显著激活和CA后肠道完整性破坏的证据。然后,使用药理学和遗传学工具,我们发现MC激活剂C48/80治疗显著增加了肠道通透性,而与野生型小鼠相比,MC缺陷小鼠的肠道功能得到了更好的保存。总之,我们的研究结果表明,MC激活是导致ca后肠道损伤的关键病理过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
SHOCK
SHOCK 医学-外科
CiteScore
6.20
自引率
3.20%
发文量
199
审稿时长
1 months
期刊介绍: SHOCK®: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. The mission of the Journal is to foster and promote multidisciplinary studies, both experimental and clinical in nature, that critically examine the etiology, mechanisms and novel therapeutics of shock-related pathophysiological conditions. Its purpose is to excel as a vehicle for timely publication in the areas of basic and clinical studies of shock, trauma, sepsis, inflammation, ischemia, and related pathobiological states, with particular emphasis on the biologic mechanisms that determine the response to such injury. Making such information available will ultimately facilitate improved care of the traumatized or septic individual.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信